Celularity Inc (CELU)
Healthcare
Biotechnology
0.66 $
+3.9%
vs. previous close
Closing price · As of: 3. Aug 2026
Celularity Inc (CELU) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Revenue" came in at 4.1 million $. Tick rows to compare them in a chart.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.9 | 3.8 | 3.8 | 15 | 12 | 9.3 | 18 | 18 | 5.7 | 5.3 | 4.1 | 4.1 | 19 | |
| 0.8 | 3.6 | 3.6 | 1.6 | 9.6 | 3.9 | 7.3 | 7.3 | 5.2 | 2.0 | 7.4 | -4.5 | 10 | |
| 2.1 | 0.2 | 0.2 | 13 | 2.5 | 5.4 | 11 | 11 | 0.5 | 3.3 | -3.3 | 8.6 | 9.0 | |
| 8.6 | 5.2 | 5.2 | 5.8 | 108 | 3.9 | 3.8 | 3.8 | 3.4 | 4.6 | 3.3 | 3.3 | 15 | |
| 13 | 11 | 13 | 14 | 13 | 13 | 16 | 16 | 13 | 9.3 | 15 | – | – | |
| 45 | 20 | 99 | 22 | -11 | 17 | 28 | 20 | 16 | 16 | 26 | 31 | 89 | |
| -42 | -16 | -99 | -7.4 | 13 | -12 | -9.5 | -9.3 | -16 | -13 | -22 | -22 | -73 | |
| 1.1 | 1.0 | 1.0 | 1.1 | 0.7 | 1.8 | 1.8 | 1.8 | 1.9 | 1.5 | 0.9 | 0.9 | 5.2 | |
| -48 | -94 | -94 | -22 | 9.6 | -16 | -13 | -13 | -25 | -23 | -24 | -24 | -96 | |
| -3.2 | – | 2.1 | – | 0.0 | -13 | – | 13 | – | 0.0 | – | 0.0 | – | |
| -48 | -94 | -94 | -22 | 9.5 | -16 | -13 | -13 | -25 | -23 | -24 | -24 | -96 | |
| -45 | – | -91 | – | -8.6 | -12 | – | -7.6 | -21 | -20 | – | -22 | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.